Yarrow Bioscience Inc
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| YARW | NBP | ACTI.ST | SPRB | ZURA | IPSC | |
|---|---|---|---|---|---|---|
| Market cap | 138.73M | 117.16M | 102.54M | 133.96M | 387.23M | 302.40M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -9.0 | -0.8 | — | 9.4 | -5.9 | -3.7 |
| Price/book | -0.6 | 0.6 | 2.8 | 1.5 | 2.2 | 1.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −15.52% | −75.89% | −42.74% | −64.33% | +15.52% | +209.26% |
| Today | −18.84% | 0.00% | +5.71% | +8.88% | +0.75% | +9.87% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All YARW news ›Yarrow Bioscience Announces Participation in November 2026 Investor Events
BioSpace Yarrow Bioscience Announces Participation in November 2026 Investor Events NEW HAVEN, Conn.--(BUSINESS WIRE)--Yarrow Bioscience, Inc. (“Yarrow” or the “Company”) (Nasdaq: YARW), a clinical-stage biotechnology compan
Financial Contrast: Yarrow Bioscience (NASDAQ:YARW) and GeoVax Labs (NASDAQ:GOVX)
Posted by Sarita Garza on Nov 1st, 2026 GeoVax Labs (NASDAQ:GOVX – Get Free Report) and Yarrow Bioscience (NASDAQ:YARW – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- biospace.com1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.